Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicenter, Double-blind, Placebo-controlled, Study Evaluating the Safety, and Efficacy of STR001 Treatment in Adults With Sudden Sensorineural Hearing Loss

NCT03331627 is registered in ClinicalTrials.gov with Strekin AG as lead sponsor.

NCT NCT03331627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03331627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicenter, Double-blind, Placebo-controlled, Study Evaluating the Safety, and Efficacy of STR001 Treatment in Adults With Sudden Sensorineural Hearing Loss
Lead sponsor
Strekin AG
Phase
Phase 3
Overall status
Completed
Start date
February 24, 2018
Completion date
February 6, 2020
Enrollment
165 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute hearing loss